Hamilton, E. P., Han, H. S., Kalinsky, K., Abuhadra, N., McAndrew, N. P., Spira, A. I., Chan, N., Starks, D., Wulf, G. M., Chaudhry, A., Kelley, K., Parajuli, R., Wang, J. S., O'Shaughnessy, J., Weise, A. M., Richardson, D. L., Roque, D. R., Ferrarotto, R., Zizlsperger, N., Giordano, A. (2025). Initial phase 1 dose escalation data for emiltatug ledadotin (Emi-Le), a novel B7-H4-directed dolasynthen antibody-drug conjugate.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3009